Overview Fundamentals API Earnings EOD API Sample Code Pricing

Edesa Biotech Inc (EDSA NASDAQ) stock market data APIs

$4.63 -0.24(-4.9%) as of July 17, 2024
Price chart is built with Anychart

Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in Covid-19 patients; and EB01, a topical vanishing cream containing non-steroidal anti-inflammatory compound that has completed Phase 2b clinical study to treat chronic allergic contact dermatitis. The company also develops EB02, an extension of secretory phospholipase 2 anti-inflammatory cream for treating erythema, swelling, and exudation associated with hemorrhoids disease; and EB06, an anti- chemokine ligand 10 (CXCL10) monoclonal antibody in vitiligo. It has a collaboration agreement with NovImmune SA to develop monoclonal antibodies targeting products containing toll-like receptor 4 and CXCL10 for therapeutic, prophylactic, and diagnostic applications in humans and animals; and Yissum Research Development Company for the development of products for therapeutic, prophylactic, and diagnostic uses in topical dermal and anorectal applications, as well as for the use in dermatologic and gastrointestinal conditions. The company was founded in 2015 and is headquartered in Markham, Canada.

Edesa Biotech Inc Financial Data Overview

4.87
4.63
-
4.92
4.3006
2.46-7
15 340 K
3 216 K
500
-0.58
0.868
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'EDSA',
Type: 'Common Stock',
Name: 'Edesa Biotech Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000R0LC72',
ISIN: 'CA27966L1085',
CUSIP: '85855A104',
CIK: '1540159',
EmployerIdNumber: NULL,
FiscalYearEnd: 'September',
IPODate: '2015-11-05',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Edesa Biotech Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 500
  • EBITDA -8 370 349
  • Earnings Per Share -19.93
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Edesa Biotech Inc Earnings via APIs

  • Latest Release 2024-05-10
  • EPS/Forecast -0.69

Get Edesa Biotech Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com